Benitec Biopharma Inc expected to post a loss of 11 cents a share - Earnings Preview

Benitec Biopharma

10/02/2023 15:40

* Benitec Biopharma Inc  BNTC.OQ   BNTC.O  is expected
to show a
fall in quarterly revenue when it reports  results on February
13 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Benitec Biopharma
Inc is
for a loss of 11 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Benitec
Biopharma
Inc is $4​, above​ its last closing price of $0.27. ​​​

This summary was machine generated February 10 at 15:40 GMT. 
All figures in US dollars  unless otherwise stated